Contact lens & anterior eye : the journal of the British Contact Lens Association · 2025
Improved control efficacy of a novel aspherical orthokeratology lens compared with the traditional three-zone spherical lens in a single-blind randomized clinical trial.
СтатьяРандомизированное исследованиеМногоцентровое исследованиеСравнительное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Luo Yuehan, Xie Juan, Liao Wenchuan, Luo Yue, Liu Jia, Liu Yuxia, Tang Yangyu, Zou Yunchun
Аннотация
PURPOSE: Orthokeratology lenses slow myopia progression by over 50% on average. Efficacy and optical outcomes of aspherical and spherical orthokeratology lens designs in controlling myopia progression are compared, focusing on axial length (AL), choroidal thickness (CHT), and relative peripheral refractive errors.
METHODS: A multicenter, single-blind, randomized controlled trial was conducted in Sichuan, China (2022-2023), with 30 participants aged 8-13 (mean age 10.8 ± 1.8 years; 70 % male). Inclusion criteria embraced refractive errors between -0.75 and -6.00 D. Each eye was randomly assigned to a spherical or aspherical lens. Measurements included AL and central corneal thickness and retinal defocus at baseline and 3, 6, 9, and 12 months.
RESULTS: No baseline differences were observed between groups (P > 0.05). Throughout the 12 months, axial length (AL) increases were reported as 0.04 ± 0.18 mm and 0.25 ± 0.23 mm in the aspherical and spherical groups, respectively (P < 0.001). The aspherical lens produced greater corneal reshaping (nasal: 65.67 μm vs. 61.23 μm, P = 0.008; temporal: 68.03 μm vs. 61.07 μm, P = 0.002) and less hyperopic defocus (RDV30-45 and RDV45-53; P < 0.001). The change in AL correlated positively with the change in RDV. No other significant between-group differences in CHT changes were observed (P = 0.203).
CONCLUSION: Aspherical orthokeratology lenses show superior control of axial length compared to spherical lens designs due to increased sagittal height and peripheral myopic defocus within 15°-45° of retinal eccentricity.
METHODS: A multicenter, single-blind, randomized controlled trial was conducted in Sichuan, China (2022-2023), with 30 participants aged 8-13 (mean age 10.8 ± 1.8 years; 70 % male). Inclusion criteria embraced refractive errors between -0.75 and -6.00 D. Each eye was randomly assigned to a spherical or aspherical lens. Measurements included AL and central corneal thickness and retinal defocus at baseline and 3, 6, 9, and 12 months.
RESULTS: No baseline differences were observed between groups (P > 0.05). Throughout the 12 months, axial length (AL) increases were reported as 0.04 ± 0.18 mm and 0.25 ± 0.23 mm in the aspherical and spherical groups, respectively (P < 0.001). The aspherical lens produced greater corneal reshaping (nasal: 65.67 μm vs. 61.23 μm, P = 0.008; temporal: 68.03 μm vs. 61.07 μm, P = 0.002) and less hyperopic defocus (RDV30-45 and RDV45-53; P < 0.001). The change in AL correlated positively with the change in RDV. No other significant between-group differences in CHT changes were observed (P = 0.203).
CONCLUSION: Aspherical orthokeratology lenses show superior control of axial length compared to spherical lens designs due to increased sagittal height and peripheral myopic defocus within 15°-45° of retinal eccentricity.